How is the Protara Therapeutics Inc today?

The Protara Therapeutics Inc today is trading in the down by -2.88% at 3.04.

How has Protara Therapeutics Inc performed historically?

The Protara Therapeutics Inc is currently trading down -2.88% on an intraday basis in the past week the index fell -2.88%. The index has been down -18.72% in the past quarter and rose 8.19% in the past year. You can view this in the overview section.

What is Protara Therapeutics Inc Annual Net Profit?

Protara Therapeutics Inc Annual Net Profit fell 10.33% in the last year to $44.6 M. Its sector's average net profit growth for the last fiscal year was -11.09%.

What is Protara Therapeutics Inc Price to Earning Ratio?

Protara Therapeutics Inc Price to Earning Ratio is -2.58, which is negative.

What is Protara Therapeutics Inc Stock Price?

Protara Therapeutics Inc Stock Price rose 8.19% and underperformed its sector by 47.28% in the past year.

What is Protara Therapeutics Inc Quarterly Net profit?

Protara Therapeutics Inc Quarterly Net profit fell 7.38% YoY to $11.91 M. Its sector's average net profit growth YoY for the quarter was -212.88%.

What is Protara Therapeutics Inc Debt to Equity Ratio?

Protara Therapeutics Inc Debt to Equity Ratio of 0.03 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

What is Protara Therapeutics Inc Return on Equity(ROE)?

Protara Therapeutics Inc Return on Equity(ROE) for the last financial year was -37.88%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Protara Therapeutics Inc Mutual Fund Holding?

Protara Therapeutics Inc Mutual Fund Holding increased by 1.07% in the last quarter to 9.65.

What is Protara Therapeutics Inc Promoter Share Holding?

Protara Therapeutics Inc Promoter Share Holding increased by 0.76% in the most recent quarter to 26.5%.

What is Protara Therapeutics Inc Institutional Holding?

Protara Therapeutics Inc Institutional Holding decreased by 2.91% in the last quarter to 73.79.

Protara Therapeutics Inc XNAS: TARA

Protara Therapeutics Inc Live Share Price Today, Share Analysis and Chart

Name: Protara Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Protara Therapeutics Inc
Rating: 1.52291675
Author: Trendlyne DVM scores

about

Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with cancer and rare diseases. The company discovers, develops and delivers breakthrough therapies to people who have limited treatment options. It...

3.04 -0.09 (-2.88%)

70.99% Fall from 52W High

340.7K XNAS Volume

XNAS 30 May, 2025 5:30 PM (EDT)

Board Meeting

The next board meeting for Protara Therapeutics Inc is on 11 Jun 2025 for the purpose of Protara Therapeutics Inc Annual General Meeting for 2025 See details

Not Eligible

Expensive Valuation

12.7 / 100

Technically Neutral

48.3 / 100

No estimates available

Protara Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Protara Therapeutics Inc Live Share Price Today, Share Analysis and Chart

Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with cancer and rare diseases. The company discovers, develops and delivers breakthrough therapies to people who have limited treatment options. It...

70.99% Fall from 52W High

SWOT Analysis

Protara Therapeutics Inc Live Price Chart

Protara Therapeutics Inc FAQ

How is Protara Therapeutics Inc today?

Protara Therapeutics Inc today is trading in the red, and is down by -2.88% at 3.04.

How has Protara Therapeutics Inc performed historically?

Protara Therapeutics Inc is currently trading down -2.88% on an intraday basis. In the past week the stock fell -2.88%. stock has been down -18.72% in the past quarter and rose 8.19% in the past year. You can view this in the overview section.